Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -38.54M | -8096.85% | $ 476K |
3/31/2025 | $ -42.19M | -6973.88% | $ 605K |
12/31/2024 | $ -39.83M | -7950.1% | $ 501K |
9/30/2024 | $ -34M | -6896.55% | $ 493K |
6/30/2024 | $ -28.43M | -5849.18% | $ 486K |
3/31/2024 | $ -29.08M | -6874.47% | $ 423K |
12/31/2023 | $ -28.45M | -6710.38% | $ 424K |
9/30/2023 | $ -32.2M | -9094.92% | $ 354K |
6/30/2023 | $ -35.07M | -8616.95% | $ 407K |
3/31/2023 | $ -33.49M | -8414.32% | $ 398K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for VYNE THERAPEUTICS INC is calculated as follows: EBIT [ $ -251.19M ] / Revenues [ $ 16.71M ]
(=) EBIT % [ -1503.51% ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |